113 related articles for article (PubMed ID: 6480707)
21. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
22. Production of heparin-binding endothelial mitogens by bovine uterine fibroblastic and epithelial cells.
Johnson ML; Redmer DA; Reynolds LP
Can J Physiol Pharmacol; 1996 Sep; 74(9):1079-86. PubMed ID: 8960401
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
Majack RA; Clowes AW
J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
[TBL] [Abstract][Full Text] [Related]
24. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors.
Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA
Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278
[TBL] [Abstract][Full Text] [Related]
25. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
Geistlich A; Gehring H
Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
[TBL] [Abstract][Full Text] [Related]
26. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro.
Thommen R; Humar R; Misevic G; Pepper MS; Hahn AW; John M; Battegay EJ
J Cell Biochem; 1997 Mar; 64(3):403-13. PubMed ID: 9057098
[TBL] [Abstract][Full Text] [Related]
27. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor.
Grako KA; Stallcup WB
Exp Cell Res; 1995 Nov; 221(1):231-40. PubMed ID: 7589250
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor mediated release of platelet-derived growth factor from bovine cerebral microvascular endothelial cells.
Li J; Zhang M; Rui YC
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):133-6. PubMed ID: 10072964
[TBL] [Abstract][Full Text] [Related]
29. The preliminary characterization of mitogens secreted by embryonic chick wing bud tissues in vitro.
Bell KM
J Embryol Exp Morphol; 1986 Apr; 93():257-65. PubMed ID: 3525735
[TBL] [Abstract][Full Text] [Related]
30. Growth regulators in connective tissues. II. Evidence for the presence of several growth inhibitors in aortic extracts.
Eisenstein R; Harper E; Kuettner KE; Schumacher B; Matijevitch B
Paroi Arterielle; 1979 Oct; 5(3):163-9. PubMed ID: 537830
[TBL] [Abstract][Full Text] [Related]
31. Heparin-like molecules as regulators of atherogenesis.
Rosenberg RD; Fritze LM; Castellot JJ; Karnovsky MJ
Nouv Rev Fr Hematol (1978); 1984; 26(4):255-60. PubMed ID: 6473095
[TBL] [Abstract][Full Text] [Related]
32. Heparin potentiates endothelial cell growth factor stimulation of plasminogen activator synthesis by diploid human lung fibroblasts.
Rappaport RS; Ronchetti-Blume M; Vogel RL; Hung PP
Thromb Haemost; 1988 Jun; 59(3):514-22. PubMed ID: 2460964
[TBL] [Abstract][Full Text] [Related]
33. Interactions between cultured bovine arterial smooth muscle cells and endothelial cells; studies on the release of growth inhibiting and growth stimulating factors.
Xu CB; Falke P; Stavenow L
Artery; 1990; 17(6):297-310. PubMed ID: 2248558
[TBL] [Abstract][Full Text] [Related]
34. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
35. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression.
Gay CG; Winkles JA
J Biol Chem; 1990 Feb; 265(6):3284-92. PubMed ID: 1689299
[TBL] [Abstract][Full Text] [Related]
36. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo.
Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE
J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo effects of endothelial cell-derived growth factor.
Gajdusek CM; Harris-Hooker SA
Adv Exp Med Biol; 1984; 172():179-203. PubMed ID: 6731145
[TBL] [Abstract][Full Text] [Related]
38. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1986 Oct; 129(1):11-9. PubMed ID: 3760032
[TBL] [Abstract][Full Text] [Related]
39. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology.
Obeso J; Weber J; Auerbach R
Lab Invest; 1990 Aug; 63(2):259-69. PubMed ID: 2166185
[TBL] [Abstract][Full Text] [Related]
40. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells.
Lorenzet R; Sobel JH; Bini A; Witte LD
Thromb Haemost; 1992 Sep; 68(3):357-63. PubMed ID: 1440505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
